AG˹ٷ

STOCK TITAN

[Form 4] Acacia Research Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Acacia Research Corp. (ACTG) � Form 4 filing: Director Gavin T. Molinelli received 8,380 shares of common stock on 30 Jun 2025 at an implied price of $3.58 per share. The stock grant was made in lieu of cash compensation for Q2-2025 board fees. Following the transaction, Molinelli’s total direct ownership increased to 150,987 shares. No dispositions or derivative transactions were reported, and no Rule 10b5-1 trading plan was indicated.

Because the shares were granted rather than purchased on the open market, the event signals board-level alignment but has limited immediate financial impact on the company. There is no effect on outstanding share count beyond routine equity compensation and no earnings or operational data were disclosed.

Acacia Research Corp. (ACTG) � Comunicazione Form 4: Il direttore Gavin T. Molinelli ha ricevuto 8.380 azioni ordinarie il 30 giugno 2025 a un prezzo implicito di 3,58 $ per azione. L'assegnazione delle azioni è stata effettuata in sostituzione della remunerazione in contanti per le commissioni del consiglio del secondo trimestre 2025. Dopo questa operazione, la proprietà diretta totale di Molinelli è aumentata a 150.987 azioni. Non sono state segnalate cessioni o operazioni su strumenti derivati, né è stato indicato un piano di trading ai sensi della Regola 10b5-1.

Poiché le azioni sono state assegnate e non acquistate sul mercato aperto, l'evento indica un allineamento a livello del consiglio, ma ha un impatto finanziario immediato limitato per la società. Non vi è alcun effetto sul numero di azioni in circolazione oltre alla normale compensazione azionaria e non sono stati divulgati dati relativi a utili o operazioni.

Acacia Research Corp. (ACTG) � Presentación Formulario 4: El director Gavin T. Molinelli recibió 8,380 acciones ordinarias el 30 de junio de 2025 a un precio implícito de $3.58 por acción. La concesión de acciones se realizó en lugar de la compensación en efectivo por las tarifas del consejo del segundo trimestre de 2025. Tras la transacción, la propiedad directa total de Molinelli aumentó a 150,987 acciones. No se reportaron disposiciones ni transacciones derivadas, ni se indicó un plan de negociación bajo la Regla 10b5-1.

Dado que las acciones fueron otorgadas y no compradas en el mercado abierto, el evento señala una alineación a nivel del consejo, pero tiene un impacto financiero inmediato limitado en la empresa. No hay efecto en el número de acciones en circulación más allá de la compensación habitual en acciones y no se divulgaron datos de ganancias u operativos.

Acacia Research Corp. (ACTG) � Form 4 제출: 이사 Gavin T. Molinelli� 2025� 6� 30일에 주당 $3.58� 암시� 가격으� 8,380�� 보통주를 받았습니�. � 주식 부여는 2025� 2분기 이사� 수수료에 대� 현금 보상 대� 이루어졌습니�. 거래 � Molinelli� 직접 소유 � 주식 수는 150,987�� 증가했습니다. 처분이나 파생 거래� 보고되지 않았으며, Rule 10b5-1 거래 계획� 명시되지 않았습니�.

주식� 공개 시장에서 구매� 것이 아니� 부여된 것이� 때문� 이번 사건은 이사� 차원� 일치� 나타내지� 회사� 대� 즉각적인 재무 영향은 제한�입니�. 일상적인 주식 보상� 제외� 유통 주식 수에� 영향� 없으�, 수익이나 운영 관� 데이터도 공개되지 않았습니�.

Acacia Research Corp. (ACTG) � Dépôt du Formulaire 4 : Le directeur Gavin T. Molinelli a reçu 8 380 actions ordinaires le 30 juin 2025 à un prix implicite de 3,58 $ par action. L'attribution des actions a été effectuée en lieu et place d'une rémunération en numéraire pour les frais du conseil d'administration du deuxième trimestre 2025. Suite à cette opération, la détention directe totale de Molinelli est passée à 150 987 actions. Aucune cession ni transaction dérivée n'a été signalée, et aucun plan de trading selon la règle 10b5-1 n'a été indiqué.

Comme les actions ont été attribuées plutôt qu'achetées sur le marché ouvert, cet événement témoigne d'une alignement au niveau du conseil d'administration, mais a un impact financier immédiat limité pour la société. Il n'y a aucun effet sur le nombre d'actions en circulation en dehors de la rémunération en actions habituelle, et aucune donnée sur les résultats ou opérations n'a été divulguée.

Acacia Research Corp. (ACTG) � Form 4 Einreichung: Direktor Gavin T. Molinelli erhielt am 30. Juni 2025 8.380 Aktien des Stammkapitals zu einem impliziten Preis von 3,58 $ pro Aktie. Die Aktienzuteilung erfolgte anstatt einer Barvergütung für die Vorstandshonorare des zweiten Quartals 2025. Nach der Transaktion erhöhte sich Molinellis direkte Gesamtbeteiligung auf 150.987 Aktien. Es wurden keine Veräußerungen oder Derivatgeschäfte gemeldet, und es wurde kein Rule 10b5-1 Handelsplan angegeben.

Da die Aktien gewährt und nicht am offenen Markt gekauft wurden, signalisiert das Ereignis eine Ausrichtung auf Vorstandsebene, hat aber begrenzte unmittelbare finanzielle Auswirkungen auf das Unternehmen. Es gibt keine Auswirkungen auf die ausstehenden Aktienzahlen über die routinemäßige Aktienvergütung hinaus, und es wurden keine Gewinn- oder Betriebsdaten offengelegt.

Positive
  • Increase in insider ownership: Director Gavin Molinelli’s stake grows to 150,987 shares, modestly enhancing board-management alignment.
Negative
  • Non-cash, routine grant: Shares were issued as compensation rather than purchased, limiting the strength of any bullish signal.

Insights

TL;DR: Small equity grant lifts director ownership; immaterial to ACTG valuation.

The Form 4 shows a routine compensation grant�8.4k shares worth roughly $30k—to Director Gavin Molinelli. His stake rises to ~151k shares, reinforcing insider alignment but not altering float meaningfully (ACTG has ~101 million shares outstanding). Because the grant is not an open-market buy, it provides only a mild positive sentiment signal and does not meaningfully change supply-demand dynamics nor forecast future fundamentals. I view the filing as neutral from a valuation perspective.

Acacia Research Corp. (ACTG) � Comunicazione Form 4: Il direttore Gavin T. Molinelli ha ricevuto 8.380 azioni ordinarie il 30 giugno 2025 a un prezzo implicito di 3,58 $ per azione. L'assegnazione delle azioni è stata effettuata in sostituzione della remunerazione in contanti per le commissioni del consiglio del secondo trimestre 2025. Dopo questa operazione, la proprietà diretta totale di Molinelli è aumentata a 150.987 azioni. Non sono state segnalate cessioni o operazioni su strumenti derivati, né è stato indicato un piano di trading ai sensi della Regola 10b5-1.

Poiché le azioni sono state assegnate e non acquistate sul mercato aperto, l'evento indica un allineamento a livello del consiglio, ma ha un impatto finanziario immediato limitato per la società. Non vi è alcun effetto sul numero di azioni in circolazione oltre alla normale compensazione azionaria e non sono stati divulgati dati relativi a utili o operazioni.

Acacia Research Corp. (ACTG) � Presentación Formulario 4: El director Gavin T. Molinelli recibió 8,380 acciones ordinarias el 30 de junio de 2025 a un precio implícito de $3.58 por acción. La concesión de acciones se realizó en lugar de la compensación en efectivo por las tarifas del consejo del segundo trimestre de 2025. Tras la transacción, la propiedad directa total de Molinelli aumentó a 150,987 acciones. No se reportaron disposiciones ni transacciones derivadas, ni se indicó un plan de negociación bajo la Regla 10b5-1.

Dado que las acciones fueron otorgadas y no compradas en el mercado abierto, el evento señala una alineación a nivel del consejo, pero tiene un impacto financiero inmediato limitado en la empresa. No hay efecto en el número de acciones en circulación más allá de la compensación habitual en acciones y no se divulgaron datos de ganancias u operativos.

Acacia Research Corp. (ACTG) � Form 4 제출: 이사 Gavin T. Molinelli� 2025� 6� 30일에 주당 $3.58� 암시� 가격으� 8,380�� 보통주를 받았습니�. � 주식 부여는 2025� 2분기 이사� 수수료에 대� 현금 보상 대� 이루어졌습니�. 거래 � Molinelli� 직접 소유 � 주식 수는 150,987�� 증가했습니다. 처분이나 파생 거래� 보고되지 않았으며, Rule 10b5-1 거래 계획� 명시되지 않았습니�.

주식� 공개 시장에서 구매� 것이 아니� 부여된 것이� 때문� 이번 사건은 이사� 차원� 일치� 나타내지� 회사� 대� 즉각적인 재무 영향은 제한�입니�. 일상적인 주식 보상� 제외� 유통 주식 수에� 영향� 없으�, 수익이나 운영 관� 데이터도 공개되지 않았습니�.

Acacia Research Corp. (ACTG) � Dépôt du Formulaire 4 : Le directeur Gavin T. Molinelli a reçu 8 380 actions ordinaires le 30 juin 2025 à un prix implicite de 3,58 $ par action. L'attribution des actions a été effectuée en lieu et place d'une rémunération en numéraire pour les frais du conseil d'administration du deuxième trimestre 2025. Suite à cette opération, la détention directe totale de Molinelli est passée à 150 987 actions. Aucune cession ni transaction dérivée n'a été signalée, et aucun plan de trading selon la règle 10b5-1 n'a été indiqué.

Comme les actions ont été attribuées plutôt qu'achetées sur le marché ouvert, cet événement témoigne d'une alignement au niveau du conseil d'administration, mais a un impact financier immédiat limité pour la société. Il n'y a aucun effet sur le nombre d'actions en circulation en dehors de la rémunération en actions habituelle, et aucune donnée sur les résultats ou opérations n'a été divulguée.

Acacia Research Corp. (ACTG) � Form 4 Einreichung: Direktor Gavin T. Molinelli erhielt am 30. Juni 2025 8.380 Aktien des Stammkapitals zu einem impliziten Preis von 3,58 $ pro Aktie. Die Aktienzuteilung erfolgte anstatt einer Barvergütung für die Vorstandshonorare des zweiten Quartals 2025. Nach der Transaktion erhöhte sich Molinellis direkte Gesamtbeteiligung auf 150.987 Aktien. Es wurden keine Veräußerungen oder Derivatgeschäfte gemeldet, und es wurde kein Rule 10b5-1 Handelsplan angegeben.

Da die Aktien gewährt und nicht am offenen Markt gekauft wurden, signalisiert das Ereignis eine Ausrichtung auf Vorstandsebene, hat aber begrenzte unmittelbare finanzielle Auswirkungen auf das Unternehmen. Es gibt keine Auswirkungen auf die ausstehenden Aktienzahlen über die routinemäßige Aktienvergütung hinaus, und es wurden keine Gewinn- oder Betriebsdaten offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Molinelli Gavin

(Last) (First) (Middle)
777 THIRD AVENUE, 18TH FLOOR

(Street)
NEW YORK NY 10017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ACACIA RESEARCH CORP [ ACTG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.001 06/30/2025 A 8,380(1) A $3.58 150,987 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of shares of Common Stock in lieu of cash for Q2 2025 director fees.
/s/ Gavin T. Molinelli 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ACTG shares did Director Gavin Molinelli receive in the latest Form 4?

He was granted 8,380 shares of Acacia Research common stock.

At what price were the shares valued in the Form 4 filing?

The grant reflects an implied price of $3.58 per share.

What is Gavin Molinelli's total ACTG ownership after the transaction?

Following the grant, he directly owns 150,987 shares.

Was the transaction an open-market purchase?

No. The shares were issued in lieu of cash director fees, not bought on the open market.

Does this Form 4 filing affect Acacia Research’s share count?

It adds a small number of shares as part of normal compensation; the impact on total float is immaterial.
Acacia Resh Corp

NASDAQ:ACTG

ACTG Rankings

ACTG Latest News

ACTG Latest SEC Filings

ACTG Stock Data

351.99M
94.81M
1.79%
88.43%
1.33%
Business Equipment & Supplies
Patent Owners & Lessors
United States
NEW YORK